Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.

Gisell CastilloManoj LaluSarah AsadMadison FosterNatasha KekreDean FergussonTerry HawryshHarold AtkinsKednapa ThavornJoshua MontroyStuart SchwartzRobert HoltRaewyn BroadyJustin Presseaunull null

Published in: Trials (2021)

ClinicalTrials.gov Identifier: NCT03765177 . Registered on December 5, 2018.

Keyphrases

cell therapy
end stage renal disease
ejection fraction
chronic kidney disease
stem cells
clinical trial
mesenchymal stem cells
prognostic factors
study protocol
randomized controlled trial
patient reported outcomes
bone marrow
patient reported
open label